Exero Medical, a company focused on early detection of post-operative complications using tissue healing data, has secured up to $12.7 million in funding to complete its FDA trial and launch its breakthrough-designated xBar system in the United States.
The round includes $10 million in upfront funding and additional milestone-based warrants, as well as $2.7 million in non-dilutive grants.
The...
